IL102921A0IL102921AIL10292192AIL102921A0IL 102921 A0IL102921 A0IL 102921A0IL 102921 AIL102921 AIL 102921AIL 10292192 AIL10292192 AIL 10292192AIL 102921 A0IL102921 A0IL 102921A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
xanthine derivatives
containing xanthine
derivatives
Prior art date
Application number
IL102921A
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/131,785external-prioritypatent/US4965271A/en
Application filed by Hoechst Roussel Pharma, Univ VirginiafiledCriticalHoechst Roussel Pharma
Priority to IL102921ApriorityCriticalpatent/IL102921A0/en
Publication of IL102921A0publicationCriticalpatent/IL102921A0/en
Pharmaceutical formulations containing 1,3-disubstituted-7- (oxohydrocarbyl) xanthine derivatives for inhibiting the activity of leukocyte- derived cytokines